US Patent 8518421 Flashmelt oral dosage formulation
Patent 8518421 was granted and assigned to Bristol-Myers Squibb on August, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 16, 2011
Date of Patent
August 27, 2013
Patent Application Number
13108193
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8518421 Flashmelt oral dosage formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
